Several major drugs companies have announced big cuts to the amounts they charge for their vaccines in the developing world. GlaxoSmithKline (GSK), Merck, Johnson & Johnson and Sanofi-Aventis have agreed to cut prices through the international vaccine alliance Gavi.
GSK said it would cut the price of its vaccine for rotavirus by 67% to $US2.50 a dose in poor countries.
Rotavirus-related diarrhoea kills more than 500,000 children a year.
The vaccine will be subsidised by higher prices being